SCHEMBL315816

SCHEMBL315816

O=C(NC1CCC(Cc2ccccc2)(N2CCOCC2)CC1)c1cccnc1Sc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
P2RX7 Q99572 1/20 0.51
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
HSD11B1 P28845 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
CNR2 P34972 2/20 0.38
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL316570 0.93 ALDH1A1 (0.56) ALDH1A1P2RX7HTTATMHSD11B1
SCHEMBL315994 0.75 ALDH1A1 (0.49) ALDH1A1HTTHSD11B1SMN1; SMN2L3MBTL1
SCHEMBL316655 0.75 ALDH1A1 (0.49) ALDH1A1HTTATMHSD11B1SMN1; SMN2
SCHEMBL316531 0.73 ALDH1A1 (0.52) ALDH1A1HTTATMHSD11B1SMN1; SMN2
SCHEMBL314971 0.73 ALDH1A1 (0.56) ALDH1A1HTTATMHSD11B1SMN1; SMN2
SCHEMBL316412 0.73 L3MBTL1 (0.51) ALDH1A1HTTATMHSD11B1SMN1; SMN2
SCHEMBL316180 0.73 ALDH1A1 (0.51) ALDH1A1HTTATMHSD11B1SMN1; SMN2
SCHEMBL316867 0.71 CNR2 (0.54) ALDH1A1CNR2CNR1
SCHEMBL316670 0.71 CNR2 (0.56) ALDH1A1KMT2AMEN1CNR2CNR1
SCHEMBL317010 0.69 L3MBTL1 (0.46) ALDH1A1MAPTL3MBTL1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP claimed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US claimed
JP-2007536321-A 2007-12-13 JP claimed
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-06-07 US claimed
EP-1745009-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2007-01-24 EP claimed
WO-2005110971-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2005-11-24 WO claimed
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP disclosed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US disclosed
EP-1745009-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2007-01-24 EP disclosed
WO-2005110971-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds DDC, DPYD, PKD1 ALDH1A1 119/4885P2RX7 2408/4885HTT 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.